Wester, Hans Jürgen;Keller, Ulrich;Schottelius, Margret;Beer, Ambros;Philipp-Abbrederis, Kathrin;Hoffmann, Frauke;Šimeček, Jakub;Gerngross, Carlos;Lassmann, Michael;Herrmann, Ken;Pellegata, Natalia;Rudelius, Martina;Kessler, Horst;Schwaiger, Markus.Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging.Theranostics.2015.618-630

Máté, Gábor;Šimeček, Jakub;Pniok, Miroslav;Kertész, István;Notni, Johannes;Wester, Hans-Jürgen;Galuska, László;Hermann, Petr.The Influence of the Combination of Carboxylate and Phosphinate Pendant Arms in 1,4,7-Triazacyclononane-Based Chelators on Their 68Ga Labelling Properties.Molecules.2015.20.13112-13126

Weineisen, M.;Schottelius, M.;Simecek, J.;Baum, R. P.;Yildiz, A.;Beykan, S.;Kulkarni, H. R.;Lassmann, M.;Klette, I.;Eiber, M.;Schwaiger, M.;Wester, H.-J..68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.Journal of Nuclear Medicine.2015.56.1169-1176

Herrmann, K.;Bluemel, C.;Weineisen, M.;Schottelius, M.;Wester, H.-J.;Czernin, J.;Eberlein, U.;Beykan, S.;Lapa, C.;Riedmiller, H.;Krebs, M.;Kropf, S.;Schirbel, A.;Buck, A. K.;Lassmann, M..Biodistribution and Radiation Dosimetry for a Probe Targeting Prostate-Specific Membrane Antigen for Imaging and Therapy.Journal of Nuclear Medicine.2015.56.855-861

Eiber, M.;Maurer, T.;Souvatzoglou, M.;Beer, A. J.;Ruffani, A.;Haller, B.;Graner, F.-P.;Kubler, H.;Haberhorn, U.;Eisenhut, M.;Wester, H.-J.;Gschwend, J. E.;Schwaiger, M..Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy.Journal of Nuclear Medicine.2015.56.668-674

Herrmann, K.;Lapa, C.;Wester, H.-J.;Schottelius, M.;Schiepers, C.;Eberlein, U.;Bluemel, C.;Keller, U.;Knop, S.;Kropf, S.;Schirbel, A.;Buck, A. K.;Lassmann, M..Biodistribution and Radiation Dosimetry for the Chemokine Receptor CXCR4-Targeting Probe 68Ga-Pentixafor.Journal of Nuclear Medicine.2015.56.410-416

Mendler, C. T.;Gehring, T.;Wester, H.-J.;Schwaiger, M.;Skerra, A..89Zr-Labeled Versus 124I-Labeled  HER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo.Journal of Nuclear Medicine.2015.56.1112-1118

Philipp-Abbrederis, K.;Herrmann, K.;Knop, S.;Schottelius, M.;Eiber, M.;Luckerath, K.;Pietschmann, E.;Habringer, S.;Gerngross, C.;Franke, K.;Rudelius, M.;Schirbel, A.;Lapa, C.;Schwamborn, K.;Steidle, S.;Hartmann, E.;Rosenwald, A.;Kropf, S.;Beer, A. J.;Peschel, C.;Einsele, H.;Buck, A. K.;Schwaiger, M.;Gotze, K.;Wester, H.-J.;Keller, U..In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.EMBO Molecular Medicine.2015.477-487

Metz, Stephan;Ganter, Carl;Lorenzen, Sylvie;van Marwick, Sandra;Holzapfel, Konstantin;Herrmann, Ken;Rummeny, Ernst J.;Wester, Hans-Jürgen;Schwaiger, Markus;Nekolla, Stephan G.;Beer, Ambros J..Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis.PLOS ONE.2015.10.e0132386

Schottelius, Margret;Wirtz, Martina;Eiber, Matthias;Maurer, Tobias;Wester, Hans-Jürgen.[111In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery.EJNMMI Research.2015